1 year return (CAGR)
-51.51%
Alnylam Pharmaceuticals Inc Exchange (NASDAQ, USD)
ALNY
224.03
+1.46 (+0.63%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
12.17%
5 year return (CAGR)
2.67%
10 year return (CAGR)
21.14%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
31.22B
Price/Sales
6.50
Ent value
33.71B
Price/Book
23.05
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
38.63
PEG
-
Forward P/E
18.78
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 232.48 |
| Daily high | 236.54 |
| Daily low | 231.25 |
| Daily Volume | 1.34M |
| All-time high | 491.22 |
| 1y analyst estimate | 371.12 |
| Beta | 0.30 |
| EPS (TTM) | 5.84 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALNY | S&P500 | |
| Current price drop from All-time high | -54.39% | -2.45% |
| Highest price drop | -83.58% | -56.47% |
| Date of highest drop | 3 Oct 2011 | 9 Mar 2009 |
| Avg drop from high | -30.86% | -10.65% |
| Avg time to new high | 30 days | 12 days |
| Max time to new high | 1443 days | 1805 days |
News
